Clinical Trial Update: A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the long-term effect of dupilumab on skin barrier function in pediatric patients with atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (Dupixent) (Dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Dermatitis Atopic | Phase 4 | Status: ACTIVE_NOT_RECRUITING